Pharmaceutical Product Development (PPD) reported a bumper set of second quarter figures, well ahead of analysts expectations, but saw its share price take a dip anyway.
Encorium Group has just announced its intention to acquire an
oncology-focused contract research organisation (CRO), along with
plans to merge with another entity that will offer it a wider
global reach.
Quotient BioResearch has consolidated its three latest drug
development acquisitions under a united front and the hungry firm
is now on the hunt for further purchases.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Chiltern, Veeda
Oncology, Icon Clinical and Pharmanet.
Synchron Research has revealed it is close to opening up new
operations in Vietnam and Hong Kong - within the next six months -
and has just bought a new business in France and strengthened its
ties with Parexel.
Pharmaceutical Product Development (PPD) has initiated central
laboratory services in China in response to the country's budding
clinical trials scene.
Dublin-based contract research organisation (CRO) Icon Clinical
Research has forayed further into Eastern Europe with the opening
of three new offices there.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Encorium Group,
Holmes Biopharma and Novotech.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving PPD, PRA, Accutest
and Premier Research.
While contract research organisations (CROs) now dominate the
clinical trials market, questions are being raised about the risks
of 'commercialising' clinical studies, according to new research.
Averion has formed a new partnership in South America's clinical
trial hotspot Brazil - as it continues to tip-toe beyond North
America and Europe into emerging markets.
Two big players in the early stage contract research organisation
(CRO) arena have announced this week they are expanding their
preclinical capabilities in Canada as demand for preclinical
testing is rising.
Two North American contract research organisation (CROs) have this
week announced acquisitive moves into emerging clinical trials
markets, while a third firm has extended an Asian partnership, as
the emerging market migration continues.
Russian contract research organisation (CRO) Synergy Research Group
has hooked up with a US-based CRO in a bid to expand its services
to North America.
The total contract research organisation (CRO) market is expected
to reach $24bn (€18bn) by 2010 as biopharma companies' spending on
outsourcing services continues to soar, new research reveals.
Quintiles is planning to spend $19m ($14m) to consolidate its US
central lab and its clinical services office in
Georgia to one location and expand capacity at the same
time.
Chiltern, Patheon, Hill Top Research, AMRI, Perceptive Informatics,
Xceleron and Charles River Labs have all had people on the move in
the world of pharmaceutical outsourcing.
Asterand said it is to slash 10 per cent of its total workforce in
a cost-cutting strategy although it is not a knock-on effect of the
recent ban on export of human samples from Russia.
Just as the clinical trials sector in Russia is
starting to take off, the industry has been dealt a severe
blow with the sudden and indefinite banning of biological sample
exports.
The first contract research service alliance (CROSA) in China has
been formed between three leading local firms to provide a more
exhaustive range of drug development services to pharma companies.
Outsourced pharmaceutical R&D spending is set to increase
at twice the expected rate of general R&D expenditure
for the next five years, according to new research published this
week.
Charles River has posted first quarter results that beat analysts
expectations after seeing renewed growth in its research models and
services segment.
Kendle has climbed back into the black in the first quarter of 2007
after another quarter of strong sales although pre-tax profit
remains down on 2006.
Parexel has announced healthy financial results for its third
fiscal quarter, despite another disappointing performance in its
medical communications business.
Contract research organisation (CRO) Chiltern has announced it is
expanding its services with a new solution aimed at helping clients
boost their clinical research staff recruitment process - an
increasingly difficult task due to...
French contract research organisation (CRO) Porsolt & Partners
Pharmacology has signed a co-marketing deal with Singapore-based
start-up Maccine to co-promote their respective preclinical service
offerings to pharma and biotech...
INC Research has become the latest contract research organisation
(CRO) to dive into India, whilst Pharmaceutical Products
Development (PPD) has opened offices in Athens and Seattle.
Indian contract research organisation (CRO) Synchron has acquired
local start-up CRO Innovance - a first-of-its-kind buyout in this
booming area of the pharma market.
Medifacts International has sold its contract research organisation
(CRO) unit after a reorganisation sparked by the firm's filing for
Chapter 11 bankruptcy protection in February.
Bridge Pharmaceuticals has just launched a new training scheme
between its facilities in the US and China to enable its employees
to cross train in both labs - a potential competitive advantage for
a contract research organisation...
Hesperion has opened a Russian arm of its contract research
business in a bid to 'increase its attractiveness' to clinical
trial sponsors requiring large patient populations.
In the next one to two years there will be a trend towards
significant reductions in clinical outsourcing/contract research
organisation (CRO) budgets in the majority of biopharma firms,
reveals a recent industry survey.
